Stock Comparison
CRL vs NTRA
Charles River Laboratories and Natera Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$12.97B
$45.32B
P/E (TTM)
—
—
Forward P/E
24.5
—
Price/Sales
3.3
16.7
Price/Book
4.6
24.9
EV/EBITDA
71.0
-26.2
Dividend Yield
—
—
Profitability
Net Margin
-4.59%
-9.05%
Operating Margin
11.77%
-12.97%
Return on Equity
-7.52%
-12.50%
Return on Assets
4.11%
-8.08%
Growth (YoY)
Revenue Growth
-2.70%
37.70%
Earnings Growth
-17.30%
0.00%
Price & Risk
Beta
1.4
1.5
52-Week High
$284.41
$322.10
52-Week Low
$145.57
$158.44
Analyst Target
$270.86
$292.38
Compare CRL and NTRA your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.